Modified albumin-bilirubin grade predicts overall and progression-free survival in metastatic gastric cancer.

Sargın F, Gok Sargin Z, Karaduru Avci A, Cetin Cansiz F, Beypinar I, Urun M, Ilhan Y, Celebi S.

Open source

DOI
10.17305/bb.2026.14188
Published
2026-05-05
Container
Biomol Biomed
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17305/bb.2026.14188,
  title = {Modified albumin-bilirubin grade predicts overall and progression-free survival in metastatic gastric cancer.},
  author = {Sargın F and  Gok Sargin Z and  Karaduru Avci A and  Cetin Cansiz F and  Beypinar I and  Urun M and  Ilhan Y and  Celebi S.},
  year = {2026},
  journal = {Biomol Biomed},
  doi = {10.17305/bb.2026.14188},
  url = {https://doi.org/10.17305/bb.2026.14188}
}

RIS

TY  - JOUR
TI  - Modified albumin-bilirubin grade predicts overall and progression-free survival in metastatic gastric cancer.
AU  - Sargın F
AU  -  Gok Sargin Z
AU  -  Karaduru Avci A
AU  -  Cetin Cansiz F
AU  -  Beypinar I
AU  -  Urun M
AU  -  Ilhan Y
AU  -  Celebi S.
PY  - 2026
JO  - Biomol Biomed
DO  - 10.17305/bb.2026.14188
UR  - https://doi.org/10.17305/bb.2026.14188
ER  - 

APA

F, S., Z, G. S., A, K. A., F, C. C., I, B., M, U., Y, I., & S., C. (2026). Modified albumin-bilirubin grade predicts overall and progression-free survival in metastatic gastric cancer.. Biomol Biomed. https://doi.org/10.17305/bb.2026.14188

Source records